Altimmune gears up for FDA meeting on pivotal Phase 3 trial in alcohol use disorder
Altimmune is gearing up to talk to the FDA next month about a pivotal program for its glucagon/GLP-1 dual receptor…
Altimmune is gearing up to talk to the FDA next month about a pivotal program for its glucagon/GLP-1 dual receptor…